European studies released last weekend suggest a link between Sonofi-Aventis' diabetes drug Lantus and cancer. Two database analyses found an increase in cancer risk, especially breast cancer, amont Lantus patients compared to people using other forms of insulin. The data is not conclusive, but does arouse suspicion that should not be ignored when treating patients.
Lantus has the second largest share of the diabetic drug treatment market. The drug was approved by FDA for diabetes in 2000.
Subscribe to:
Post Comments (Atom)
Posts
Two database analyses found an increase in cancer risk, especially breast cancer, amont Lantus patients compared to people using other forms of insulin. The data is not conclusive, but does arouse suspicion that should not be ignored when treating patients. anticancer treatments
ReplyDelete